Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. Jul 6, 2024; 12(19): 4003-4009
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.4003
Table 1 Main features of unicentric Castleman disease

Features
Ref.
EpidemiologyIncidence (United States): 16–19 cases per million person-years. No gender predominance[2,3]
CauseProbable clonal neoplastic condition: Benign neoplasm of FDCs[4,10-14]
Risk factorsNot known[10]
Clinical presentationSingle lymph node mass (non-tender lymphadenopathy): Asymptomatic or manifesting as pain, sensation of heaviness, compression of organs, and anatomic structures (e.g., chest lesions). In the plasma cell subtype: Fever, fatigue, and laboratory abnormalities (IL-6 secretion: Elevated ESR, elevated CRP, anemia)[1,4-7,9,15,16,20,21]
Disorders associatedPolyneuropathy, Hodgkin disease, non-Hodgkin lymphoma, and follicular dendritic cell sarcoma[16,20,21]
SiteMediastinum, neck, abdominal cavity, retroperitoneum, and pelvis. Less frequently in axillary or inguinal regions[5,7]
ImagingUseful for differential diagnosis: Ultrasonography, CT, MRI[15,20]
Differential diagnosisLymphomas; cancer (e.g., lymph node metastasis); benign proliferative lesions (e.g., thymoma); inflammatory processes (e.g., sarcoidosis); infections (e.g., tuberculosis)[17,18]
Histopathology Confirm the diagnosis: Hyaline vascular or plasma cell-type aspects[8,20]
VirologyHHV-8 negative[18]
TherapySurgical excision is preferred. Radiotherapy, embolization, or systemic therapy for non-resectable symptomatic lesions[5,19-21]
OutcomeLong-term follow-up to monitor for potential recurrences[22]